Myriad Genetics Inc
DUS:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
DUS:MYD
|
US |
|
First Hartford Corp
OTC:FHRT
|
US |
|
Bell Food Group AG
SIX:BELL
|
CH |
|
Intouch Insight Ltd
XTSX:INX
|
CA |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
H
|
Highland Copper Company Inc
OTC:HDRSF
|
CA |
|
ABC Arbitrage SA
F:9BA
|
FR |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
XP Inc
NASDAQ:XP
|
KY |
|
MLP Saglik Hizmetleri AS
IST:MPARK.E
|
TR |
|
R
|
Ratchthani Leasing PCL
SET:THANI
|
TH |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
DK |
|
S
|
Schweizer Electronic AG
F:SCE
|
DE |
|
M
|
Moody's Corp
XMUN:DUT
|
US |
|
S
|
State Street Corp
XMUN:ZYA
|
US |
|
B
|
Broadcom Inc
F:1YD
|
US |
|
E
|
Essilorluxottica SA
XHAM:ESL
|
FR |
|
C
|
Cenovus Energy Incorporation
F:CXD
|
CA |
|
I
|
Infosys Ltd
BSE:500209
|
IN |
|
Lee Hing Development Ltd
HKEX:68
|
HK |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
383.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.7m USD. This includes both short-term (0 USD) and long-term (120.7m USD) debt.
You can find a full breakdown on its Balance Sheet.